Firms
Theme

HRB

H&R Block, Inc. · NYSE

News

12 latest

The Motley Fool

Pathward: 3 Key Takeaways for Long-Term Investors

Pathward reported Q4 2026 earnings with net income of $175.7 million, highlighted by a renewed H&R Block partnership through mid-2030, loan originations nearly doubling from $1.3 billion to $2.2 billion, and maintaining low revenue concentration with no single partner exceeding 5% of revenue. The company is expanding its credit sponsorship business and focusing on disciplined growth.

Zacks Investment Research

H&R Block Gains From Tax Resilience & AI Amid Volume Pressures

H&R Block reported strong FY26 results with assisted tax revenues up 6.1% and Wave growing 12.3%, supported by AI-driven efficiencies that boosted EBITDA 8.3% and adjusted EPS 13.9% to $5.31. However, the company faces headwinds from declining DIY volumes (-5.6%), rising technology costs, and intense competition, increasing reliance on pricing to sustain growth.

Zacks Investment Research

Are Consumer Discretionary Stocks Lagging H&R Block (HRB) This Year?

H&R Block (HRB) and Imax (IMAX) are outperforming the Consumer Discretionary sector year-to-date. HRB has returned 2.3% versus the sector's -11.1% decline, with improved earnings estimates and a Zacks Rank #2 (Buy). IMAX has surged 38.8% with an 18.2% increase in consensus EPS estimates over three months, also holding a Zacks Rank #2 (Buy).

Zacks Investment Research

Here's Why H&R Block (HRB) is a Strong Value Stock

Zacks Premium offers investment research tools including the Zacks Rank stock-rating system and Style Scores to help investors identify stocks with strong performance potential. The service features daily updates, equity research reports, and stock screens. H&R Block (HRB) is highlighted as a Strong Buy with attractive valuation metrics and positive earnings estimate revisions.

Zacks Investment Research

New Strong Buy Stocks for October 6th

Zacks has added five stocks to its Strong Buy list today: Sandisk Corporation, Calumet Inc., Chevron Corporation, H&R Block Inc., and Goldman Sachs BDC Inc. All five companies have seen their consensus earnings estimates increase over the last 60 days, ranging from 8.1% to 15.3%.

Zacks Investment Research

Best Growth Stocks to Buy for October 6th

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong growth characteristics: BP p.l.c. with 32.4% earnings estimate increase, KE Holdings Inc. with 22.5% earnings estimate increase, and H&R Block Inc. with 8.1% earnings estimate increase. All three companies have favorable PEG ratios compared to their respective industries and possess a Growth Score of B.

Zacks Investment Research

Best Income Stocks to Buy for October 6th

Zacks highlights three Rank #1 stocks with strong income characteristics: Goldman Sachs BDC with a 14.1% dividend yield and 12.2% earnings estimate increase; H&R Block with a 4.4% dividend yield and 8.1% earnings estimate increase; and Canadian Natural Resources with a 3.7% dividend yield and 6% earnings estimate increase.

Zacks Investment Research

H&R Block Stock Gains 30% in 6 Months: Here's What You Should Know

H&R Block (HRB) stock has gained 30.1% over six months, outperforming its industry. The company's growth is driven by AI Tax Assist handling 4.1M client messages (88% YoY increase), Wave's double-digit revenue growth from Pro-Tier subscriptions, and a strong balance sheet with $978M cash and no debt. Operating cash flow increased 23% YoY, while the company continues shareholder-friendly dividend and buyback programs.

Zacks Investment Research

How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks

With traditional retirement income sources like Treasury bonds and Social Security becoming less reliable, the article recommends dividend-paying stocks from high-quality companies as an alternative income strategy for retirees. Three specific stocks are highlighted: Bristol Myers Squibb (3.94% yield), Horace Mann (3.20% yield), and H&R Block (4.56% yield), all offering steady dividend growth that can help combat inflation while reducing portfolio volatility.

Mentions HRB

Zacks Investment Research

Intuit's Lower DIY Tax Pricing: Will It Weigh on Revenue Growth?

Intuit is shifting its tax preparation strategy to prioritize customer acquisition over near-term revenue, launching competitive pricing through Credit Karma Tax (free federal, $15 state filing) while maintaining TurboTax's premium positioning. However, this strategy will moderate TurboTax revenue growth to 2-3% in fiscal 2027 from 7% in 2026, as the company lost 3 percentage points of DIY tax e-file market share due to pricing pressures.

Zacks Investment Research

Intuit Stock Gains Nearly 9% in 3 Months: Is More Upside Still Ahead?

Intuit (INTU) shares gained 8.7% over three months, driven by strong mid-market and financial services growth. The company projects 9-10% revenue growth for fiscal 2027, slower than fiscal 2026.

Zacks Investment Research

Intuit Targets Faster Customer Growth: Can Its Strategy Deliver?

Intuit is pivoting its fiscal 2027 strategy to prioritize new customer growth after additions slowed in key business segments. The company is launching QuickBooks Free and Lite to attract entrepreneurs earlier, while TurboTax is adjusting pricing to compete with lower-cost providers. This shift results in lower expected revenue growth of 9%-10% for fiscal 2027 versus 14% in fiscal 2026, as Intuit invests heavily in customer acquisition while betting on deeper platform monetization over time.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $HRB · 0 threads

Sign in to post on $HRB

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev